ACCESS Newswire

Surfe

15.7.2024 13:34:58 CEST | ACCESS Newswire | Press release

Share
Surfe Secures Google Cloud Executive Lloyd Rayner as Chief Revenue Officer

PARIS, FRANCE / ACCESSWIRE / July 10, 2024 / Surfe, the prospecting engine for sales teams, today announced the appointment of Lloyd Rayner as Chief Revenue Officer (CRO). Rayner, who formerly led a team of high-growth marketers at Google Cloud to generate $1.5 billion in annual pipeline, brings a wealth of experience in leading growth operations that generate demand.

"Lloyd's addition to the Surfe team marks our most significant hire to date," said David Chevalier, CEO of Surfe. "Securing talent from a household name like Google is a real achievement for us. The fact that Lloyd was able to have such a big impact on the way Google Cloud worked during his time there is something we're really excited about. Lloyd's expertise will allow Surfe to create a revolutionary prospecting engine that drives results for every sales team globally."

During his tenure at Google Cloud, Rayner worked with over 200 BDRs to scale the outbound telesales channel from $0 to $500 million per annum. Rayner has a record of pioneering growth operations for Google Cloud that are at the forefront of sales automation, including leading on the development of AI and generative AI programs to transform marketing and sales processes.

Surfe aims to use this spirit of innovation to evolve the way it brings its industry-changing product to its customers and to drive sustained growth.

"At Google Cloud, I saw firsthand how Surfe was impacting the daily workflow of sales people," said Rayner. "Together, we onboarded almost 700 sales people for prospecting and data enrichment, massively improving their productivity and effectiveness. It's part of the reason we were able to drive such sustainable growth in Google Cloud's pipeline. I also saw that Surfe was building many of the things I was working on for Google - the difference now is that, together, we can build them for everybody, at a much larger scale."

Rayner's appointment underscores Surfe's commitment to attracting top talent and strengthening its leadership team to achieve its mission: developing a prospecting engine that revolutionizes sales.

For more information, please contact Jack Bowerman, Communications Manager.

About Surfe
Surfe is a sales engine that handles prospecting from start to finish. Surfe ensures that sales teams send the right message to the right contact at the right time. Connect your CRM to LinkedIn with Surfe now.

Surfe is free for 2 weeks - Get started now.

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.

For more information, please contact:
Jack Bowerman Communications Manager Surfe
jack.bowerman@surfe.com
+ 0768695209

SOURCE: Surfe



View the original press release on accesswire.com

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.

About ACCESS Newswire

DK

Subscribe to releases from ACCESS Newswire

Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from ACCESS Newswire

AGFA HealthCare Named Best in KLAS(R) 2026 Across Three Enterprise Imaging Segments in the United States4.2.2026 15:45:00 CET | Press release

Industry recognition for the third consecutive year reinforces AGFA HealthCare's clinician-first commitment, and leadership in empowering connected, high-performance imaging environments MORTSEL, BE / ACCESS Newswire / February 4, 2026 / AGFA HealthCare today announced that it has been named Best in KLAS® 2026 across three Enterprise Imaging segments in the United States, with two awards earned for the second consecutive year, underscoring the company's continued leadership in delivering clinician-first imaging solutions trusted by healthcare organizations worldwide. The recognition comes as KLAS Research marks its 30th anniversary, celebrating three decades of amplifying the voice of healthcare providers through independent, data-driven insights. AGFA HealthCare's Best in KLAS distinctions reflect strong customer validation of its Enterprise Imaging platform - designed to empower clinicians to stay in their flow, reduce complexity across imaging workflows, and enable confident clinica

Preservica Redefines Digital Preservation with Powerful Built-In AI Tools4.2.2026 15:00:00 CET | Press release

OXFORD, UK and BOSTON, MA / ACCESS Newswire / February 4, 2026 / Preservica, the leader in AI-powered Active Digital Preservation™, today announced the rollout of integrated, human-centered AI tools and flexible AI Credits across its product editions. These new features make AI assistance a seamless part of everyday archival workflows, empowering organizations of all sizes to safely adopt AI and scale its use as their needs grow. "With the sheer volume of digital content in backlogs and being created daily, using AI to assist in archival tasks has now become essential" says Stuart Reed, Chief Product Officer at Preservica "Seamlessly integrating human-centered AI tools across our product editions turns AI for Digital Preservation into reality - enabling organizations of all sizes to accelerate routine work, cut backlogs and enhance discovery." Developed in collaboration with Preservica's user community and refined through the company's highly rated AI Workshop series, these embedded to

Karbon-X Files Quarterly Report on Form 10-Q Highlighting Strong Revenue Growth and Commercial Scale4.2.2026 15:00:00 CET | Press release

CALGARY, AB / ACCESS Newswire / February 4, 2026 / Karbon-X Corp. (OTCQX:KARX) ("Karbon-X" or the "Company"), a vertically integrated climate solutions company, today announced that it has filed its Quarterly Report on Form 10-Q for the six months ended November 30, 2025. The filing highlights continued momentum in Karbon-X's commercial operations, driven by significant revenue growth and the expansion of its global carbon activities across both compliance and voluntary markets. "Over the past several quarters, we transformed Karbon-X from a developing platform into a scaled, revenue-generating global operator," said Chad Clovis, Chief Executive Officer of Karbon-X Corp. "Revenue increased to $56.5 million (USD), compared to $1.3 million (USD) in the prior-year period, reflecting the strength of our commercial strategy and the growing demand for high-integrity carbon solutions. As we continue to invest in scaling our operations, our expanding global footprint, improved profitability, a

Axon Neuroscience's Immunotherapy Selected for a Landmark Combination-Therapy Alzheimer’s Clinical Trial in US, Supported by a USD 151 Million Grant4.2.2026 14:00:00 CET | Press release

Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a groundbreaking U.S. Alzheimer's disease phase 2 clinical trial (supported by a USD 151 million grant) and, simultaneously, a new platform trial for progressive supranuclear palsy (PSP) (supported by a USD 75 million grant) SAN FRANCISCO, CA / ACCESS Newswire / February 4, 2026 / Axon Neuroscience, a global leader in immunotherapy for human neurodegenerative diseases with an internationally recognized scientific team, announces the achievement of two historic milestones with the potential to significantly influence the future treatment of Alzheimer's disease and progressive supranuclear palsy (PSP): 1. AADvac1 Selected as the First Tau Therapy in the Phase 2 Alzheimer's Tau Platform (ATP) Combination-Therapy Trial An independent panel of leading U.S. scientific and clinical experts selected AADvac1 as the first therapy targeting pathological tau protein to be evaluated in

CHAR Technologies Licenses High-Temperature Pyrolysis Technology to GazoTech SAS for Entry Into European Markets4.2.2026 14:00:00 CET | Press release

TORONTO, ON / ACCESS Newswire / February 4, 2026 / CHAR Technologies Ltd. ("CHAR Tech" or "the Company") (TSXV:YES)(FSE:68K) a leader in sustainable biomass energy solutions, today announced that it has entered into a formal technology know-how licensing agreement with GazoTech SAS ("GazoTech"), a France-based energy developer, to support deployment of CHAR Tech's technology in France and selected European markets. The agreement follows recent commissioning progress at CHAR Tech's Thorold Renewable Energy Facility and complements the Company's ongoing development of larger-scale projects in North America. Under the agreement, CHAR Tech is the licensor of its proprietary High-Temperature Pyrolysis ("HTP") technology, granting GazoTech a know-how licence for projects developed in France as well as certain additional European markets, subject to project-by-project application of the licenced technology. GazoTech has multiple projects in development in France, notably: An industrial integr

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye